Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01775982
Other study ID # PHRC-N/2011/VA-04
Secondary ID 2011-A01161-40
Status Completed
Phase N/A
First received January 23, 2013
Last updated January 31, 2017
Start date April 2014
Est. completion date February 2, 2016

Study information

Verified date January 2017
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To validate the French version of the CAM, a multicenter diagnostic study will be conducted. The principle of this study is identical to the study of Inouye which initially validated the CAM in 1990. This is to verify the diagnostic properties of the CAM (French version) compared to the gold standard represented by the confused state of psychiatric diagnosis using the DSM.

A representative sample of geriatric patients for whom a delirium is suspected, will be recruited in the various participating centers, patients will undergo two consecutive visits:

- A visit by a geriatrician, during which the confused state of the patient will be evaluated using the French version of the CAM.

- A visit by a psychiatrist during which the diagnosis of confusional state will be evaluated using the gold standard criteria of the DSM IV.

These two evaluations will be conducted on the same day and blinded from each other.

The order of these two procedures will be balanced within each center. This process will allow the calculation of diagnostic parameters of the CAM French version (validation competitive): sensitivity, specificity, positive and negative predictive values .


Recruitment information / eligibility

Status Completed
Enrollment 102
Est. completion date February 2, 2016
Est. primary completion date February 2, 2016
Accepts healthy volunteers No
Gender All
Age group 75 Years and older
Eligibility Inclusion Criteria:

- A family member of the patient, or his/her "trusted person" must have given his/her informed and signed consent

- The patient must be insured or beneficiary of a health insurance plan

- Hospitalization in geriatric short stay OR patient consulting at a geriatric assessment center / memory clinic OR geriatric day hospitalization

- Patients for whom a state of confusion is suspected during the pre-inclusion visit run-in based on the following criteria:

- Presence of a cognitive function disorder as defined by a score greater than or equal to 3 on the Short Portable Mental Status Questionnaire (SPMSQ) (Pfeiffer E, 1975) AND / OR

- Presence of a mood disorder and / or behavior disorder (regardless of duration) according to the patient's family or caregivers

- Presence of a caregiver who can answer questionnaires concerning activities of everyday life

Exclusion Criteria:

- The patient is participating in another study

- The patient is in an exclusion period determined by a previous study

- The patient's family or "trusted-person" refuses to sign the consent

- The patient does not understand french

- Severe aphasia

- Stay is < = 3 days

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Psychiatric evaluation
This evaluation is carried out in several stages: Assessment of cognitive functioning; Interview with a relative; Interview with caregivers; Evaluation of the presence of delirium according to DSM-IV criteria; Evaluation of the presence of anxiety, depressive syndrome, dementia or other DSM IV; Reports of adverse events. A potential intervention order effect will be taken into account by balancing in each center the number of evaluations beginning with the geriatric assessment and those starting with the psychiatric assessment.
Geriatric evaluation
This evaluation includes a brief interview with a caregiver, diverse scorings (CAM, Delirium Index, Mini Geriatric Depression Scale, Modified Early Warning Score, Clinical Global Impression sclae, Algo Plus), and adverse event reporting. CAM scoring is carried out by a trained geriatrician and a trained nurse and/or a psychologist. A potential intervention order effect will be taken into account by balancing in each center the number of evaluations beginning with the geriatric assessment and those starting with the psychiatric assessment.

Locations

Country Name City State
France CH d'Alès Alès
France CHU de Rouen - Hôpital de Bois-Guillaume Bois Guillaume
France APHP - Hôpital Charles Foix Ivry Sur Seine Cedex
France APHM - Hôpital Sainte-Marguerite Marseille
France CHU de Montpellier - Centre Antonin Balmes Montpellier cedex 5
France CHU de Nice - Hôpital de Cimiez Nice
France CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09
France CHU de Reims - Hôpital Maison Blanche Reims

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other Patient age (years) Baseline (day 0)
Other Patient weight (kg) Baseline (Day 0)
Other Height (cm) Baseline (day 0)
Other Education level primary, secondary, or higher baseline (day 0)
Other Living situation (qualitative) Does the patient live at home? or is the patient institutionalized? baseline (day 0)
Other Presence/absence of a caregiver baseline (day 0)
Other Hospitalization within the past 3 months? yes/no baseline (day 0)
Other Has the patient fallen within the past year? yes/no baseline (day 0)
Other presence/absence of a visual or hearing impairment baseline (day 0)
Other patient position during evaluation qualitative variable: in bed, in a wheelchair, sitting down baseline (day 0)
Other ADL (Activities of Daily Living) score for the 15 days preceding inclusion baseline (day 0)
Other IADL (Instrumental Activities of Daily Living) score for the 15 days preceding inclusion baseline (day 0)
Other ADL (Activities of Daily Living) score at the moment of inclusion baseline (day 0)
Other Clinical and para-clinical examination baseline (day 0)
Other Evaluation of the patient's physiological state baseline (day 0)
Other Diagnosis baseline (day 0)
Other Prescribed drugs baseline (day 0)
Other Comorbidities (Charlson score) baseline (day 0)
Other History of dementia, depression or another psychiatric disorder Notification in the patient's history of dementia, depression or another psychiatric disorder, assessed by NPI-R and Mini GDS. baseline (day 0)
Other Severity of clinical condition Severity of clinical condition: MEWS (Subbe CP et al, 2001) and CGI (Guy W 1976) + Charlson scale baseline (day 0)
Other Presence or absence of dementia before admission Presence or absence of dementia before admission (IQCODE French version) (Jorm AF 1994 and Law S, 1995) baseline (day 0)
Primary CAM French Version: diagnostic properties Sensitivity, specificity, positive predictive value, negative predictive value Day 0
Secondary Reliability and quality of the french version of the CAM Parameters of reliability and quality of the tool:
Inter-rater Agreement (measured by a coefficient of correlation) between two evaluators: geriatrician and a nurse or psychologist
Internal consistency of the questionnaire assessed by calculating Cronbach's alpha
Time required for assessment
Acceptability by clinicians
Tolerance of patients
Day 0
Secondary Feasibility of scoring with the French version of the Delirium Index day 0
Secondary Diagnostic properties of alternative algorithms constructed from items of CAM (French version) day 0
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT05891873 - Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06194474 - Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
Completed NCT03095417 - Improving the Recovery and Outcome Every Day After the ICU N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Not yet recruiting NCT04846023 - Pediatric Delirium Screening in the PICU Via EEG N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Withdrawn NCT02673450 - PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
Recruiting NCT03256500 - Transcranial Direct Current Stimulation for the Treatment of Delirium N/A
Completed NCT02890927 - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital N/A
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Completed NCT02518646 - DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models N/A
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Recruiting NCT02305589 - The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium N/A
Completed NCT02628925 - Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale N/A